11:35am ET
Health and Healthcare
Top Credit Suisse Pharma Picks Ahead of Catalysts
Credit Suisse provided its outlook for several large-cap pharmaceutical stocks Monday morning. The analyst has three top picks to consider.
Companies
/Healthcare
Lilly(Eli) & Company
$1,159.60
▼ $0.48 (−0.04%) today
Markets closed · 11:34pm ET
LLY Coverage
Page 29
11:00am ET
Health and Healthcare
Merck’s Accelerated Keytruda Lung Cancer Approval Creates 3 Moves
It is no secret that pharma and biotech shares have had to deal with at least some headwinds over the past year. It turns out that drug pricing concerns and political oversight…
9:00am ET
Health and Healthcare
Short Interest in Major Pharma Shrinks
The April 28 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mostly downward.
8:20am ET
Health and Healthcare
JPMorgan Has 3 Top Pick Large Cap Pharmaceuticals to Buy for the Rest of 2017
JPMorgan has made the case that the best place for investors to look when considering large cap drug stocks is companies that have strong new product cycles already in motion.
9:05am ET
Investing
Top Analyst Upgrades and Downgrades: Amex, Cisco, Eli Lilly, First Solar, McDonald’s, Microsoft, US Steel and More
The top analyst upgrades, downgrades and other research calls on Thursday include American Express, Cisco, Eli Lilly, First Solar, McDonald's, Microsoft and U.S. Steel.
8:25am ET
Health and Healthcare
Short Sellers Can’t Make Up Their Minds on Major Pharma
The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
10:20am ET
Health and Healthcare
FDA Delivers Big Rheumatoid Athritis Disappointment for Eli Lilly and Incyte
When drugs are expected to get FDA approval and show positive data but don't, the underlying stocks of drug and biotech companies can see harsh punishment.
10:00am ET
Health and Healthcare
Top Dividend Pharmaceutical Stocks Safe Bet for Rest of 2017
With interest rates once again dropping as the geopolitical worries ratchet up, investors are concerned about owning good stocks and receiving dependable dividends. One place that looks very good now is pharmaceuticals.
8:25am ET
Health and Healthcare
Short Sellers Run for Cover From Major Pharma Stocks
The March 31 short interest data have been compared with the previous figures, and short interest decreased in most of these selected pharmaceutical stocks.
10:45am ET
Health and Healthcare
Analysts Keep Stacking Up Higher Targets and Expectations for Eli Lilly
Several analysts and market pundits have been positive toward Eli Lilly lately, including now a price target raise at JPMorgan.
Jon C. Ogg 8:35am ET
Health and Healthcare
Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote
The March 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks was mixed.
8:55am ET
Investing
Short Sellers Back Off Major Pharma
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
8:55am ET
Health and Healthcare
Why Short Sellers Are Making a Massive Bet in Major Pharma
Judging by this report, short sellers are making a tremendous bet against Trump’s plan to reform the health care sector.
8:35am ET
Health and Healthcare
Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?
It has yet to be seen how much headway Trump can actually make with heath care reforms, but so far the reaction has been quite positive.
9:50am ET
Health and Healthcare
How Eli Lilly Earnings Won Big on New Drug Sales
Eli Lilly released a mixed fourth-quarter earnings report and offered full-year guidance before the markets opened on Tuesday.
Chris Lange